Related Experiment Video
Updated: Feb 21, 2026

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Medication-taking experiences in attention deficit hyperactivity disorder: a systematic review.
Mohammed A Rashid1, Sophie Lovick2, Nadia R Llanwarne3
1UCL Medical School, London, UK.
Medication decisions for attention deficit hyperactivity disorder (ADHD) evolve with age, involving patient and caregiver trade-offs. Understanding these experiences aids clinicians in shared treatment decision-making for ADHD management.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Psychology
Background:
- Attention deficit hyperactivity disorder (ADHD) pharmacotherapy is effective but challenging to implement.
- Patient and caregiver perspectives on medication are crucial for understanding treatment challenges.
Purpose of the Study:
- To synthesize findings on medication-taking experiences in ADHD.
- To guide clinicians in shared decision-making for ADHD treatment.
Main Methods:
- Systematic search of five databases (MEDLINE, Embase, PsycINFO, SCOPUS, CINAHL).
- Quality assessment using Critical Appraisal Skills Programme checklist.
- Meta-ethnographic synthesis of 31 included articles.
Main Results:
- Studies included caregivers, pediatric, and adult patients across seven countries.
- Key constructs: accepting ADHD, medication concerns, effects, external influences, self-management.
- Medication decisions evolve towards autonomy and self-management, involving weighing benefits and harms.
Conclusions:
- Offers comprehensive insight into ADHD medication experiences.
- Highlights shifting decision-making and external influences.
- Enables holistic conversations for effective shared decision-making in primary care and mental health settings.
More Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Drug Therapy
Antianxiety Medications
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...